Valuation: DNA X, Inc.

Market Cap 5.24M 4.54M 4.24M 3.87M 7.3M 500M 7.41M 49.71M 19.51M 250M 19.67M 19.24M 832M P/E 2024
-0.44x
P/E 2025 -0.11x
Enterprise Value 9M 7.79M 7.28M 6.66M 12.54M 858M 12.74M 85.41M 33.51M 429M 33.8M 33.06M 1.43B EV / Sales 2024
0.17x
EV / Sales 2025 -
Free-Float
63.9%
Yield 2024 *
-
Yield 2025 -
1 day+1.70%
1 week-12.25%
Current month+5.54%
1 month-17.51%
3 months-30.69%
6 months-45.76%
Current year+13.65%
1 week 3.5
Extreme 3.5
4.11
1 month 2.8
Extreme 2.8
4.43
Current year 2.62
Extreme 2.62
7.97
1 year 2.52
Extreme 2.5211
16.97
3 years 2.52
Extreme 2.5211
192.6
5 years 2.52
Extreme 2.5211
1,322.28
10 years 2.52
Extreme 2.5211
32,863.47
Manager TitleAgeSince
Chief Executive Officer 63 2026-02-08
Director of Finance/CFO 64 2022-07-12
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 63 2023-11-12
Director/Board Member 64 2022-07-12
Director/Board Member 79 2022-07-12
Date Insider Type Main position Quantity % Market Cap.
2/9/26 Free

Chief Executive Officer

50,000 3.3592%
2/9/26 Free

Chief Financial Officer

35,000 2.3514%
7/18/25 Other

Director

723 0.0053%
Change 5-day change 1-year change 3-year change Capi.($)
+1.70%-12.25%-66.06%-96.37% 5.24M
+4.13%0.00%+233.57%+252.21% 1,034B
+6.41%+1.38%-14.96%+36.29% 1.78B
-0.78%-1.99%+28.31%+250.00% 1.34B
-1.50%+11.33%+74.67%+24.76% 1.09B
-0.49%+1.50%-1.82%-19.80% 1.05B
-0.39%+4.99%-17.34%+73.45% 621M
-2.84%-17.35%-6.50%+116.72% 520M
+0.23%+11.76%+25.94%+4.80% 485M
-0.41%-2.93%-26.76%+294.79% 184M
Average +0.61%+62.57%+22.90%+93.68% 104.13B
Weighted average by Cap. +4.11%-2.32%+232.06%+251.04%

Financials

2024 2025
Net sales 58.3M 50.47M 47.17M 43.11M 81.24M 5.56B 82.51M 553M 217M 2.78B 219M 214M 9.26B -
Net income -33.65M -29.13M -27.23M -24.88M -46.89M -3.21B -47.63M -319M -125M -1.61B -126M -124M -5.35B -20.66M -17.88M -16.72M -15.28M -28.79M -1.97B -29.24M -196M -76.91M -986M -77.56M -75.87M -3.28B
Net Debt -5.34M -4.63M -4.32M -3.95M -7.45M -510M -7.56M -50.7M -19.89M -255M -20.06M -19.62M -849M 3.76M 3.26M 3.04M 2.78M 5.24M 359M 5.32M 35.7M 14.01M 179M 14.13M 13.82M 598M
Logo DNA X, Inc.
DNA X, Inc., formerly Sonim Technologies, Inc., is a digital asset management platform, building on the digital asset trading platform. The Company operates an artificial intelligence (AI) and crypto trading platform designed to automate trading strategies using machine learning technologies. It provides a digital asset trading platform that allows users to trade or swap cryptocurrencies for other cryptocurrencies or cash equivalent currencies. The Company’s DNA X trading website enables users to implement strategies to take advantage of fluctuations in relative values of cryptocurrency pairs. The platform allows users to set up automated trading strategies, monitor other traders’ trading strategies in real time, and simulate trades. The Company generates revenue from trading commissions based on the value of trades executed on its platform. It serves individual investors from around the world and supports its operations through subsidiaries located in China, Germany, and Hong Kong.
Employees
4
Date Price Change Volume
26-08-11 US$3.580 +1.70% 1,287
26-08-10 US$3.520 -6.88% 14,059
26-08-07 US$3.780 -4.55% 13,722
26-08-06 US$3.960 -0.75% 17,323
26-08-05 US$3.990 -2.21% 8,626

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SONM Stock